{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:03:49Z","timestamp":1792404229480,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10792-021-01717-0","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T05:09:48Z","timestamp":1612242588000},"page":"1917-1927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Gene therapy in color vision deficiency: a review"],"prefix":"10.1007","volume":"41","author":[{"given":"Zeinab","family":"El Moussawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerita","family":"Boueiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7136-6278","authenticated-orcid":false,"given":"Christiane","family":"Al-Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"issue":"5","key":"1717_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/col.22513","volume":"45","author":"M Tekav\u010di\u010d Pompe","year":"2020","unstructured":"Tekav\u010di\u010d Pompe M (2020) Color vision testing in children. Color Res Appl 45(5):775\u2013781","journal-title":"Color Res Appl"},{"issue":"13","key":"1717_CR2","doi-asserted-by":"publisher","first-page":"17954","DOI":"10.1364\/OE.27.017954","volume":"7","author":"M Mart\u00ednez-Domingo","year":"2019","unstructured":"Mart\u00ednez-Domingo M, G\u00f3mez-Robledo L, Valero E, Huertas R et al (2019) Assessment of VINO filters for correcting red-green color vision deficiency. Opt Expr 7(13):17954","journal-title":"Opt Expr"},{"issue":"5","key":"1717_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/ICU.0000000000000189","volume":"26","author":"M Remmer","year":"2015","unstructured":"Remmer M, Rastogi N, Ranka M et al (2015) Achromatopsia. Curr Opin Ophthalmol 26(5):333\u2013340","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"1717_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3928\/01913913-20171117-01","volume":"55","author":"I Pascual-Camps","year":"2017","unstructured":"Pascual-Camps I, Barranco-Gonzalez H, Avi\u00f1\u00f3-Mart\u00ednez J et al (2017) Diagnosis and treatment options for achromatopsia: a review of the literature. J Pediatr Ophthalmol Strabismus 55(2):85\u201392","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"1717_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/bjo.2003.027102","volume":"88","author":"M Michaelides","year":"2004","unstructured":"Michaelides M, Hunt DM, Moore AT (2004) The cone dysfunction syndromes. Br J Ophthalmol 88:291\u2013297","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1717_CR6","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1167\/iovs.08-2544","volume":"50","author":"A Moskowitz","year":"2009","unstructured":"Moskowitz A, Hansen R, Akula J et al (2009) Rod and rod-driven function in achromatopsia and blue cone monochromatism. Invest Ophthalmol Vis Sci 50(2):950","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"1717_CR7","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/bjophthalmol-2012-301737","volume":"96","author":"MG Thomas","year":"2012","unstructured":"Thomas MG, Mclean RJ, Kohl S et al (2012) Early signs of longitudinal progressive cone photoreceptor degeneration in achromatopsia. Br J Ophthalmol 96(9):1232\u20131236. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-301737","journal-title":"Br J Ophthalmol"},{"key":"1717_CR8","unstructured":"Kohl S, J\u00e4gle H, Wissinger B. Achromatopsia. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews. Seattle, WA: University of Washington, Seattle; 1993\u20132017. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1418\/. Accessed Mar 23, 2017"},{"key":"1717_CR9","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00439-015-1571-4","volume":"134","author":"M Ansar","year":"2015","unstructured":"Ansar M, Santos-Cortez RL, Saqib MA et al (2015) Mutation of ATF6 causes autosomal recessive achromatopsia. Hum Genet 134:941\u2013950","journal-title":"Hum Genet"},{"key":"1717_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/ng.3319","volume":"47","author":"S Kohl","year":"2015","unstructured":"Kohl S, Zobor D, Chiang WC et al (2015) Mutations in the unfolded protein response regulator ATF6 cause the cone dysfunction disorder achromatopsia. Nat Genet 47:757\u2013765","journal-title":"Nat Genet"},{"key":"1717_CR11","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.ophtha.2014.11.025","volume":"122","author":"L Zelinger","year":"2015","unstructured":"Zelinger L, Cideciyan AV, Kohl S et al (2015) Genetics and disease expression in the CNGA3 form of achromatopsia: steps to the path to gene therapy. Ophthalmology 122:997\u20131007","journal-title":"Ophthalmology"},{"key":"1717_CR12","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1001\/jamaophthalmol.2014.1032","volume":"132","author":"S Li","year":"2014","unstructured":"Li S, Huang L, Xiao X et al (2014) Identification of CNGA3 mutations in 46 families: common cause of achromatopsia and cone-rod dystrophies in Chinese patients. JAMA Ophthalmol 132:1076\u20131083","journal-title":"JAMA Ophthalmol"},{"key":"1717_CR13","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1093\/hmg\/ddp440","volume":"18","author":"XQ Ding","year":"2009","unstructured":"Ding XQ, Harry CS, Umino Y et al (2009) Impaired cone function and cone degeneration resulting from CNGB3 deficiency: down-regulation of CNGA3 biosynthesis as a potential mechanism. Hum Mol Genet 18:4770\u20134780","journal-title":"Hum Mol Genet"},{"issue":"257","key":"1717_CR14","first-page":"259","volume":"19","author":"S Kohl","year":"1998","unstructured":"Kohl S, Marx T, Giddings I et al (1998) Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel. Nat Genet 19(257):259","journal-title":"Nat Genet"},{"key":"1717_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ajhg.2009.06.016","volume":"85","author":"AA Thiadens","year":"2009","unstructured":"Thiadens AA, den Hollander AI, Roosing S et al (2009) Homozygosity mapping reveals PDE6C mutations in patients with early-onset cone photoreceptor disorders. Am J Hum Genet 85:240\u2013247","journal-title":"Am J Hum Genet"},{"key":"1717_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/b978-1-4557-0737-9.00044-8","author":"DM Wu","year":"2013","unstructured":"Wu DM, Fawzi AA (2013) Abnormalities of cone and rod function. Retina. https:\/\/doi.org\/10.1016\/b978-1-4557-0737-9.00044-8","journal-title":"Retina"},{"key":"1717_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-323-65414-2.00009-x","author":"D Toffoli","year":"2019","unstructured":"Toffoli D, Mathews M, Almeida T et al (2019) Genetic abnormalities of the optic nerve and color vision. Ophthalmic Genet Dis. https:\/\/doi.org\/10.1016\/b978-0-323-65414-2.00009-x","journal-title":"Ophthalmic Genet Dis"},{"key":"1717_CR18","doi-asserted-by":"publisher","unstructured":"Deeb SS, Motulsky AG (2019) Chapter 133 - color vision defects. Elsevier 1\u201317 https:\/\/doi.org\/10.1016\/B978-0-12-383834-6.00142-7","DOI":"10.1016\/B978-0-12-383834-6.00142-7"},{"key":"1717_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.optm.2007.04.088","volume":"78","author":"HI Zeltzer","year":"2007","unstructured":"Zeltzer HI (2007) The use of tinted contact lenses in the management of achromatopsia. Optometry 78:328","journal-title":"Optometry"},{"key":"1717_CR20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nbt.2643","volume":"31","author":"A Gonzalez-Cordero","year":"2013","unstructured":"Gonzalez-Cordero A, West EL, Pearson RA et al (2013) Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina. Nat Biotechnol 31:741\u2013747","journal-title":"Nat Biotechnol"},{"key":"1717_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2014.05.001","volume":"42","author":"S Roosing","year":"2014","unstructured":"Roosing S, Thiadens AA, Hoyng CB et al (2014) Causes and consequences of inherited cone disorders. Prog Retin Eye Res 42:1\u201326","journal-title":"Prog Retin Eye Res"},{"key":"1717_CR22","doi-asserted-by":"publisher","first-page":"6810","DOI":"10.1167\/iovs.15-16866","volume":"56","author":"D Marangoni","year":"2015","unstructured":"Marangoni D, Vijayasarathy C, Bush RA et al (2015) Intravitreal ciliary neurotrophic factor transiently improves cone-mediated function in a CNGB3-\/- mouse model of achromatopsia. Invest Ophthalmol Vis Sci 56:6810\u20136822","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"suppl 2","key":"1717_CR23","first-page":"29","volume":"15","author":"SM Petersen-Jones","year":"2010","unstructured":"Petersen-Jones SM (2010) Viral vectors for targeting the canine retina: a review. Vet Ophthalmol 15(suppl 2):29\u201334","journal-title":"Vet Ophthalmol"},{"key":"1717_CR24","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1167\/iovs.09-4367","volume":"51","author":"JH Sweigard","year":"2010","unstructured":"Sweigard JH, Cashman SM, Kumar-Singh R (2010) Adenovirus vectors targeting distinct cell types in the retina. Invest Ophthalmol Vis Sci 51:2219\u20132228","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1717_CR25","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1093\/hmg\/ddu426","volume":"24","author":"W Du","year":"2015","unstructured":"Du W, Tao Y, Deng WT et al (2015) Vitreal delivery of AAV vectored CNGA3 restores cone function in CNGA3-\/-\/Nrl-\/- mice, an all-cone model of CNGA3 achromatopsia. Hum Mol Genet 24:3699\u20133707","journal-title":"Hum Mol Genet"},{"key":"1717_CR26","unstructured":"Center for biologics evaluation and research. (2018). What is gene therapy? Retrieved August 26, 2020, from https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/what-gene-therapy"},{"issue":"2","key":"1717_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1172\/JCI126205","volume":"129","author":"KE Uyhazi","year":"2019","unstructured":"Uyhazi KE, Bennett J (2019) Blinded by the light: a nonhuman primate model of achromatopsia. J Clin Invest 129(2):513\u2013515","journal-title":"J Clin Invest"},{"key":"1717_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-020-0174-4","author":"I Trapani","year":"2020","unstructured":"Trapani I, Tornabene P, Auricchio A (2020) Large gene delivery to the retina with AAV vectors: Are we there yet? Gene Ther. https:\/\/doi.org\/10.1038\/s41434-020-0174-4","journal-title":"Gene Ther"},{"issue":"492","key":"1717_CR29","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1126\/scitranslmed.aav4523","volume":"11","author":"P Tornabene","year":"2019","unstructured":"Tornabene P, Trapani I, Minopoli R et al (2019) Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina. Sci Transl Med 11(492):4523","journal-title":"Sci Transl Med"},{"issue":"2","key":"1717_CR30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1172\/JCI123980","volume":"129","author":"A Moshiri","year":"2019","unstructured":"Moshiri A, Chen R, Kim S et al (2019) A nonhuman primate model of inherited retinal disease. J Clin Investig 129(2):863\u2013874","journal-title":"J Clin Investig"},{"issue":"3","key":"1717_CR31","doi-asserted-by":"publisher","first-page":"e2944","DOI":"10.1002\/jgm.2944","volume":"19","author":"S Michalakis","year":"2017","unstructured":"Michalakis S, Sch\u00f6n C, Becirovic E, Biel M (2017) Gene therapy for achromatopsia. J Gene Med 19(3):e2944","journal-title":"J Gene Med"},{"key":"1717_CR32","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1167\/iovs.04-1503","volume":"46","author":"S Michalakis","year":"2005","unstructured":"Michalakis S, Geiger H, Haverkamp S et al (2005) Impaired opsin targeting and cone photoreceptor migration in the retina of mice lacking the cyclic nucleotide-gated channel CNGA3. Invest Ophthalmol Vis Sci 46:1516\u20131524","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1717_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ygeno.2009.10.003","volume":"95","author":"S Reicher","year":"2010","unstructured":"Reicher S, Seroussi E, Gootwine E (2010) A mutation in gene CNGA3 is associated with day blindness in sheep. Genomics 95:101\u2013104","journal-title":"Genomics"},{"issue":"6","key":"1717_CR34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.gt.3303074","volume":"15","author":"M Natkunarajah","year":"2008","unstructured":"Natkunarajah M, Trittibach P, McIntosh J et al (2008) Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2\/8. Gene Ther 15(6):463\u2013467. https:\/\/doi.org\/10.1038\/sj.gt.3303074","journal-title":"Gene Ther"},{"issue":"3","key":"1717_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/mt.2008.269","volume":"17","author":"H Petrs-Silva","year":"2009","unstructured":"Petrs-Silva H, Dinculescu A, Li Q et al (2009) High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol Ther 17(3):463\u2013471. https:\/\/doi.org\/10.1038\/mt.2008.269","journal-title":"Mol Ther"},{"issue":"5","key":"1717_CR36","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/mt.2008.41","volume":"16","author":"K Stieger","year":"2008","unstructured":"Stieger K, Colle MA, Dubreil L et al (2008) Subretinal delivery of recombinant AAV serotype 8 vector in dogs results in gene transfer to neurons in the brain. Mol Ther 16(5):916\u2013923. https:\/\/doi.org\/10.1038\/mt.2008.41","journal-title":"Mol Ther"},{"key":"1717_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00292","author":"R M\u00fchlfriedel","year":"2017","unstructured":"M\u00fchlfriedel R, Tanimoto N, Sch\u00f6n C et al (2017) AAV-mediated gene supplementation therapy in achromatopsia type 2: preclinical data on therapeutic time window and long-term effects. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2017.00292","journal-title":"Front Neurosci"},{"issue":"4","key":"1717_CR38","doi-asserted-by":"publisher","first-page":"e35250","DOI":"10.1371\/journal.pone.0035250","volume":"7","author":"J Pang","year":"2012","unstructured":"Pang J, Deng W, Dai X et al (2012) AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia. PLoS ONE 7(4):e35250","journal-title":"PLoS ONE"},{"issue":"12","key":"1717_CR39","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1038\/mt.2010.149","volume":"18","author":"S Michalakis","year":"2010","unstructured":"Michalakis S, M\u00fchlfriedel R, Tanimoto N et al (2010) Restoration of cone vision in the CNGA3\u2212\/\u2212 mouse model of congenital complete lack of cone photoreceptor function. Mol Ther 18(12):2057\u20132063","journal-title":"Mol Ther"},{"issue":"11","key":"1717_CR40","doi-asserted-by":"publisher","first-page":"e0188032","DOI":"10.1371\/journal.pone.0188032","volume":"12","author":"X Dai","year":"2017","unstructured":"Dai X, He Y, Zhang H et al (2017) Long-term retinal cone rescue using a capsid mutant AAV8 vector in a mouse model of CNGA3-achromatopsia. PLoS ONE 12(11):e0188032","journal-title":"PLoS ONE"},{"issue":"9","key":"1717_CR41","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/mt.2015.114","volume":"23","author":"E Banin","year":"2015","unstructured":"Banin E, Gootwine E, Obolensky A et al (2015) Gene augmentation therapy restores retinal function and visual behavior in a sheep model of CNGA3 achromatopsia. Mol Ther 23(9):1423\u20131433","journal-title":"Mol Ther"},{"issue":"3","key":"1717_CR42","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1167\/iovs.16-20986","volume":"58","author":"E Gootwine","year":"2017","unstructured":"Gootwine E, Abu-Siam M, Obolensky A et al (2017) Gene augmentation therapy for a missense substitution in the cGMP-binding domain of ovine CNGA3 gene restores vision in day-blind sheep. Investig Opthalmol Vis Sci 58(3):1577","journal-title":"Investig Opthalmol Vis Sci"},{"issue":"6","key":"1717_CR43","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/jamaophthalmol.2020.1032","volume":"138","author":"M Fischer","year":"2020","unstructured":"Fischer M, Michalakis S, Wilhelm B et al (2020) Safety and vision outcomes of subretinal gene therapy targeting cone photoreceptors in achromatopsia. JAMA Ophthalmol 138(6):643","journal-title":"JAMA Ophthalmol"},{"key":"1717_CR44","unstructured":"- Safety and efficacy trial of aav gene therapy in patients with CNGA3 Achromatopsia - Full Text View - clinicaltrials.gov [Internet]. Clinicaltrials.gov. 2020 [visited on 28 August 2020]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02935517"},{"issue":"13","key":"1717_CR45","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1093\/hmg\/ddq136","volume":"19","author":"A Kom\u00e1romy","year":"2010","unstructured":"Kom\u00e1romy A, Alexander J, Rowlan J et al (2010) Gene therapy rescues cone function in congenital achromatopsia. Hum Mol Genet 19(13):2581\u20132593","journal-title":"Hum Mol Genet"},{"issue":"16","key":"1717_CR46","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1093\/hmg\/ddr218","volume":"20","author":"L Carvalho","year":"2011","unstructured":"Carvalho L, Xu J, Pearson R et al (2011) Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy. Hum Mol Genet 20(16):3161\u20133175","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1717_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1089\/hum.2015.130","volume":"27","author":"G Ye","year":"2016","unstructured":"Ye G, Budzynski E, Sonnentag P et al (2016) Cone-specific promoters for gene therapy of achromatopsia and other retinal diseases. Hum Gene Ther 27(1):72\u201382","journal-title":"Hum Gene Ther"},{"key":"1717_CR48","unstructured":"Safety and efficacy trial of AAV gene therapy in patients with CNGB3 Achromatopsia - Full Text View - ClinicalTrials.gov [Internet]. Clinicaltrials.gov. 2020 [visited on 28 August 2020]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02599922"},{"key":"1717_CR49","unstructured":"Gene therapy for achromatopsia (CNGB3) - Full Text View - ClinicalTrials.gov [Internet]. Clinicaltrials.gov. 2020 [visited on 28 August 2020]. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03001310"},{"key":"1717_CR50","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/hmg\/9.14.2107","volume":"9","author":"S Kohl","year":"2000","unstructured":"Kohl S, Baumann B, Broghammer M et al (2000) Mutations in the CNGB3 gene encoding the betasubunit of the cone photoreceptor cGMP-gated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21. Hum Mol Genet 9:2107\u20132116","journal-title":"Hum Mol Genet"},{"issue":"6","key":"1717_CR51","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nm1596","volume":"13","author":"J Alexander","year":"2007","unstructured":"Alexander J, Umino Y, Everhart D et al (2007) Restoration of cone vision in a mouse model of achromatopsia. Nat Med 13(6):685\u2013687","journal-title":"Nat Med"},{"key":"1717_CR52","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/978-1-4419-1399-9_73","volume":"2009","author":"J Pang","year":"2009","unstructured":"Pang J, Alexander J, Lei B et al (2009) Achromatopsia as a potential candidate for gene therapy. Retinal Degener Dis Adv Exp Med Biol 2009:639\u2013646. https:\/\/doi.org\/10.1007\/978-1-4419-1399-9_73","journal-title":"Retinal Degener Dis Adv Exp Med Biol"},{"issue":"7265","key":"1717_CR53","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/nature08401","volume":"461","author":"K Mancuso","year":"2009","unstructured":"Mancuso K, Hauswirth W, Li Q et al (2009) Gene therapy for red\u2013green colour blindness in adult primates. Nature 461(7265):784\u2013787","journal-title":"Nature"},{"issue":"14","key":"1717_CR54","first-page":"1403","volume":"52","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Pang J, Xia F et al (2011) AAV-mediated gene therapy restores cone function in a rat with an M-cone opsin deficiency, a model for blue cone monochromacy. Invest Ophthalmol Vis Sci 52(14):1403\u20131403","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"1717_CR55","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1167\/iovs.19-27079","volume":"60","author":"W Deng","year":"2019","unstructured":"Deng W, Li J, Zhu P et al (2019) Rescue of M-cone function in aged Opn1mw\u2212\/\u2212 mice, a model for late-stage blue cone monochromacy. Invest Ophthalmol Vis Sci 60(10):3644","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01717-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-01717-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-01717-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T14:34:25Z","timestamp":1619793265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-01717-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1717"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-01717-0","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"16 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}